Beyond Air: Commercial Momentum and Global Expansion Driven by LungFit PH
Wednesday, February 25, 2026
11:00 AM – 12:00 PM ET
Review this insightful fireside discussion with Steve Lisi, Chief Executive Officer of Beyond Air, Inc. (NASDAQ: XAIR), and Jason Kolbert, Head of Research at D. Boral Capital. The conversation highlights the company’s growing commercial foundation anchored by LungFit PH, including real-world hospital adoption, utilization trends, and the expanding role of nitric oxide delivery as a differentiated respiratory therapy platform.
This webinar focuses on Beyond Air’s execution across both domestic and international markets, including continued progress in U.S. hospital penetration, distributor-driven expansion abroad, and the operational milestones supporting broader market access. Management also provides perspective on the evolution towards the second-generation LungFit PH system and how improvements may enhance ease of use, scalability, and economic value for healthcare systems.
The session further explores key catalysts expected to shape the company’s trajectory through 2026, including continued commercial growth and expansion opportunities, the regulatory progress for LungFit PH enhancements, and potential for platform extension into additional pulmonary indications. Corporate development initiatives are discussed in the context of Beyond Air’s overall strategic focus, with emphasis remaining on execution within the core franchise.
This post-earnings discussion offers investors a timely opportunity to hear directly from Beyond Air leadership regarding the company’s operational momentum and value drivers.